RE:RE:An Infusion Deal Actually, Dr. Sen has always said that "any benefits and formulation research conducted by IBS will transfer to Sproutly".
I'm not sure if you know how marketing works, but any exposure to the APP technology is a bonus to all Sproutly investors...
"...It's APP Technology is being commercialized in Canada and other international markets via its licensee Sproutly Inc., which trades on the CSE."